 - Relapsed or refractory after at least 1 prior therapy for AL amyloidosis and, in the investigators opinion, require further treatment. Participants with a history of autologous stem cell transplantation must have adequate blood counts independent of growth factor support and have recovered from any transplant-related toxicities and be at least 100 days post-autologous transplant. 